Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study

• Autores principales: Huiqiong Zeng (Autor), Hanjiang Liu (Autor), Zhi Liu (Autor), Xiakai Zhou (Autor), Xiaoping Lu (Autor), Zhenbo Yan (Autor), Yan Zhou (Autor), Liping Dai (Autor), Yashuo Chen (Autor), Tingting Yang (Autor), Zhihua Yin (Autor), Zhizhong Ye (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Patients with rheumatic diseases (RD) are considered to be a high-risk population for infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The effectiveness of inactivated COVID-19 vaccinations (ICVs) was described as more effective than 95%. Despite this, no data on the...